http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20040071540-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_04c43185014be9fbd479adc649574c9b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-46 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14 |
| filingDate | 2003-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_075c56047be9113ed02ab3904285a23e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b1ec89a46f6917051cb4a1898e952bb |
| publicationDate | 2004-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20040071540-A |
| titleOfInvention | New cephalosporin compounds |
| abstract | The present invention relates to a novel cephalosporin compound and derivatives thereof, and more particularly, a 1,8-naphthyridine derivative is substituted at the C-3 position of the cefe nucleus, and an aminothiazole derivative is substituted at the C-7 position. The present invention relates to novel cephalosporin compounds, pharmacologically acceptable salts and isomers thereof, which are acylated and represented by the following general formula (1), and methods for their preparation.n n n [Formula 1]n n n n n n n n In Formula 1, R is methyl or carboxypropyl. |
| priorityDate | 2003-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 76.